The chemical substance with the name "(2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol" and CAS number "2015222-35-0" is a complex organic compound characterized by its specific stereochemistry and functional groups. It features a tetrahydrofuran ring, which is a five-membered cyclic ether, and is substituted with a hydroxymethyl group and a purine derivative, indicating potential biological activity. The presence of an amino group and a chlorine atom suggests that this compound may exhibit unique reactivity and interactions, particularly in biological systems. Its stereochemical configuration, denoted by the (2S,3R,4S,5R) notation, indicates the specific three-dimensional arrangement of atoms, which is crucial for its biological function and interaction with enzymes or receptors. This compound may be of interest in medicinal chemistry, particularly in the development of nucleoside analogs or other therapeutic agents targeting nucleic acid metabolism. Further studies would be necessary to elucidate its specific properties, mechanisms of action, and potential applications.

(2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

2015222-35-0: The chemical substance with the name "(2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol" and CAS number "2015222-35-0" is a complex organic compound characterized by its specific stereochemistry and functional groups. It features a tetrahydrofuran ring, which is a five-membered cyclic ether, and is substituted with a hydroxymethyl group and a purine derivative, indicating potential biological activity. The presence of an amino group and a chlorine atom suggests that this compound may exhibit unique reactivity and interactions, particularly in biological systems. Its stereochemical configuration, denoted by the (2S,3R,4S,5R) notation, indicates the specific three-dimensional arrangement of atoms, which is crucial for its biological function and interaction with enzymes or receptors. This compound may be of interest in medicinal chemistry, particularly in the development of nucleoside analogs or other therapeutic agents targeting nucleic acid metabolism. Further studies would be necessary to elucidate its specific properties, mechanisms of action, and potential applications.

CAS 2015222-35-0

(2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Regadenoson Impurity 2

Ref: ST-EA-CP-R55005